Pharmaceutical preparations company · NV · FY ends Dec · Revenue $2M · -614.95% margin
The business is unprofitable at the operating level (-1627.55% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 1002.0% YoY with margins expanding 581.6pp.
ROIC dropped from -23.52% to -192.42%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
$2M
▲ +1002.0% YoY
Net Income (TTM)
-$10M
▼ -697.8% YoY
Op. Margin
-614.95%
▲ +581.6pp YoY
ROIC
-197.35%
▼ -168.9pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$316K
▲ +61.2% YoY
Net Debt
-$82K
Net Cash Position
Cash & Equiv.
$88K
3Y CAGR: +165.8%
Continue Research